Navigation Links
Morphine Painkillers Won't Impair Driving
Date:10/13/2007

Study found no difference in motorists' reaction times

SATURDAY, Oct. 13 (HealthDay News) -- Moderate, long-term use of opioid pain medications such as morphine does not impair a person's driving ability, U.S. researchers report.

A team at Rush University Medical Center in Chicago compared two groups of people -- 51 long-term users of oral morphine and 49 who weren't taking any pain medication. All the participants spent about 12 minutes in a driving simulator that measured deviation from the center of the road, weaving, number of accidents, and reaction time to unexpected events.

The average amount of weaving for both groups was 3.83 feet, and the morphine group had 5.33 collisions, compared with 5.04 collisions for the control group. Average reaction time for the morphine group was 0.67 seconds, compared with 0.69 seconds for the control group.

The findings suggest that patients who require long-term pain medication may "become tolerant" to side effects that could potentially impair function, said researcher Dr. Asokumar Buvanendran, an associate professor in the anesthesiology department at Rush.

The study was expected to be presented Oct. 13 at the annual meeting of the American Society of Anesthesiologists, in San Francisco.

Opioid pain relievers carry warning labels urging patients not to drive or operate heavy machinery while taking the medications, and drivers under the influence of pain drugs are typically subject to the same laws and penalties as people who drink and drive.

According to Buvanendran, this study's findings suggest that patients on long-term pain medication may be able to live "like normal functioning people, without the stigma and limitations now associated with long-term pain medication use."

More information

The American Academy of Family Physicians has more about chronic pain medicines.



-- Robert Preidt



SOURCE: American Society of Anesthesiologists, news release, Oct. 13, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Morphine may excite cancerous tumors
2. Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers
3. Inhibition of morphine tolerance by spinal melanocortin receptor blockade
4. Using Morphine to Hasten Death Is a Myth, Says Doctor
5. How Morphine Affects Memory
6. Painkillers Do Not Shorten Dying Patients Lives
7. Drug dilemma confronts users of painkillers
8. Painkillers may protect against Alzheimers disease
9. Painkillers may raise miscarriage risk
10. Painkillers Increase Risk of Miscarriage
11. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
Breaking Medicine Technology: